Navigation Links
Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
Date:6/3/2011

icity 55%). 'High-risk' patients had a significantly higher probability of recurrence within 36 months than 'low-risk' patients (PPV 0.51, NPV 0.73, HR 2.06 (95% CI: 1.10 to 3.86; p=0.020)). In contrast, the standard prognostic guidelines described by the NCCN Guidelines were unable to differentiate recurrence risk in this population (p=0.315).

Notably, the study found that Stage I colorectal cancer patients that were deemed 'high-risk' by the test recurred at a rate more than triple that for patients deemed 'low-risk'. "The updated data demonstrate that OncoDefender-CRC provides a more targeted stratification of patients, independent of other recognized prognostic variables, such as age, T-stage, grade, tumor location and lymphovascular invasion," said Lenehan.

Recent research in cancer genomics has shown that Stage I/II colorectal cancer tumors can differ greatly from other tumors that are classified in the same stage, indicating that some tumors present observable high-risk characteristics. Tumors that present such high-risk characteristics can be more than 20 times more likely to lead to a recurrence than tumors with low-risk characteristics. By more accurately identifying patients who have high-risk tumors, Lenehan said healthcare providers can more effectively target their treatment decisions, thereby potentially improving clinical outcomes.

"Recent literature shows that patients identified with high-risk early stage tumors benefit significantly from surgical removal of the tumor followed by adjuvant therapy," Lenehan said. "Until recently, however, physicians have not been equipped with prognostic tests that can accurately distinguish high-risk early stage tumors from low-risk tumors."

"The data from the OncoDefender-CRC study validate the effectiveness of this node-negative prognostic test in determining recurrence risk for this population, demonstrating the potential for optimizing post-op clinical management and patient stratif
'/>"/>

SOURCE Everist Genomics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Everist Genomics Announces Worldwide Availability of OncoDefender™-CRC
2. Genetics Squared Changes Name To Everist Genomics
3. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
4. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
5. Rosetta Genomics Announces Issuance of Additional U.S. Patent
6. WaferGen Appoints World-Renowned Clinical Genomics Cancer Researcher Dr. Arul M. Chinnaiyan to Scientific Advisory Board
7. NeoGenomics Awarded $374,000 in R&D Grants from the US Government
8. NeoGenomics Schedules its Q3 2010 Earnings Release for October 28, 2010
9. BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure
10. Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
11. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014  Advanced Medical Isotope Corporation ... engaged primarily in the development of brachytherapy devices ... today announced that a Life Sciences Discovery Fund ... for which AMIC is the commercialization partner.  The ... for the proposal titled "Optimized Injectable Radiogels for ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , Dec. ... SRNE ;  Sorrento), an oncology company developing ... Conkwest, Inc., a privately-held immuno-oncology company developing proprietary ... cell-line based therapy, announced today that the companies ... develop next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... Shire plc (LSE: SHP,NASDAQ: SHPGY ), the ... pending litigation with Sandoz, Inc. ("Sandoz") in,connection with Sandoz,s ... generic versions of Shire,s ADDERALL XR(R) (mixed,amphetamine salts) for ... The settlement also provides Sandoz with a ...
... Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today announced ... of Patrick J. McEnany,s employment agreement with the Company ... , The Company announced that Steven R. Miller, ... Dr. Miller, currently Catalyst,s Vice President, Pharmaceutical Development ...
Cached Medicine Technology:Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 2Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 3Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executive's Employment Agreement 2Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executive's Employment Agreement 3
(Date:12/22/2014)... December 22, 2014 The Bob ... ever, having invested more than $5 million in ... veterans and their families. , This includes $1.3 ... dozen nonprofits, helping with: veteran entrepreneurship; community impact; ... life-coaches for severely injured veterans. , “The needs ...
(Date:12/22/2014)... Give a loved one the greatest gift ... and vitality. , For a limited time, HealthiPlus ( ... in special Holiday Wellness gift packages at drastically reduced ... bottle contains cutting-edge, proven nutritional support for joints, mental ... as we age. , Joint Health Plus ...
(Date:12/22/2014)... 22, 2014 Xarelto Lawsuit News ... of judges has granted a request to centralize pending ... District Court, Eastern District of Louisiana. The U.S. Judicial ... December 12 to transfer over 50 Xarelto cases–21 lawsuits ... the Louisiana court for consolidation under U.S. District Judge ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Christmas is days ... has a fast and easy solution that will please: the ... can be purchased from from $25 up to $350," says ... 100% customer satisfaction and a wide array of skin care ... fees and no expiration dates. , Gift delivery past ...
(Date:12/22/2014)... The NLN’s 2015 Leadership Institute ... month. Faculty have been selected through competitive application ... for administrative leadership roles within their academic institutions; ... Educators, featuring a curriculum uniquely devised for up-and-comers ... , Twenty nurse educators were chosen for the ...
Breaking Medicine News(10 mins):Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3
... Blue Cross Blue Shield of Michigan has,been named 2007 ... Michigan,Minority Business Development Council., The award recognizes the ... of suppliers to the corporation., "Blue Cross Blue ... because it recognizes our strong commitments to diversity and ...
... infants make distinctions based on behaviors , , WEDNESDAY, Nov. 21 (HealthDay ... learned language can still judge who is friend and who is ... who cooperate versus people who hurt, and this ability could be ... the Yale researchers. Their study is published in the Nov. 22 ...
... Susan G. Komen for the Cure, the,nation,s ... research and,community-based outreach programs, is accepting applications to ... a,parent to breast cancer., (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ... students cover the costs of,tuition, books, fees and ...
... (Amex: IMA ), announced today that it closed ... a total,of 13,634,302 shares in the offering at a ... of shares sold by the Company included,1,800,000 shares sold ... in full. Certain selling stockholders of the Company,also sold ...
... widespread and often deadly among older American women, doctors ... to a new report by a team of vascular ... Cornell Medical College campuses of NewYork-Presbyterian Hospital. , Much ... years, cardiovascular research has focused almost exclusively on males, ...
... CITY, Calif., Nov. 21 Genomic Health,Inc. (Nasdaq: ... Ph.D., Genomic,Health,s Chairman and Chief Executive Officer, will ... New York, NY on November 28, 2007 at ... and subsequently archived webcast of the,presentation, visit the ...
Cached Medicine News:Health News:Blue Cross Blue Shield of Michigan Named 2007 Corporation of the Year in Health Care by Michigan Minority Business Development Council 2Health News:Babies Can Tell Friend From Foe 2Health News:Susan G. Komen for the Cure Provides Scholarships for Students Who Lost a Parent to Breast Cancer 2Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 2
... Care Xpress is an innovative, stat analyzer ... hematology with on-board co-oximetry and integrated data ... Measured tests include pH, PCO 2 , ... and hemoglobin, sodium, potassium, chloride, ionized calcium, ...
... Kohden developed the world's first ... was completely AC powered in ... developed a number of standard ... measuring systems, such as a ...
... in Digital EEG ,The company that ... presents the latest addition to the ... This innovative system incorporates the latest ... information management to offer you unprecedented ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: